CEM Corporation Launches New Disruptive Technology for Transforming and Simplifying Microwave Digestion

(Matthews, North Carolina, May 22, 2019) – CEM Corporation, the leading supplier of microwave digestion systems, is pleased to announce the latest breakthrough in vessel technology which dramatically simplifies and improves the overall digestion process. It allows the use of simple disposable glass vessels through the entire sample preparation process from the balance to the analyzer. This includes... Read more

CEM Corporation Launches New Disruptive Technology for Transforming and Simplifying Microwave Digestion

(Matthews, North Carolina, May 22, 2019) – CEM Corporation, the leading supplier of microwave digestion systems, is pleased to announce the latest breakthrough in vessel technology which dramatically simplifies and improves the overall digestion process. It allows the use of simple disposable glass vessels through the entire sample preparation process from the balance to the analyzer. This includes... Read more

Consolidated Financial Statements for the Year Ended March 31, 2019 FY2019 (April 1, 2018 – March 31, 2019)[UNAUDITED]

This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 14 May 2019 Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. Parties elect to refile Premerger Notification and Report Forms on or about 23 May 2019 to provide the government with additional... Read more

First-of-its-kind Commercial MicroED Solution Helps Researchers Quickly Resolve Organic and Inorganic Molecular Structures at Atomic Resolution

First-of-its-kind Commercial MicroED Solution Helps Researchers Quickly Resolve Organic and Inorganic Molecular Structures at Atomic Resolution The comprehensive offering from Thermo Fisher can improve outcomes in materials and life sciences research HILLSBORO, Ore., April 25, 2019 /PRNewswire/ — Researchers and scientists analyzing crystallized protein samples in life sciences and materials research can now benefit from... Read more

Rigaku Oxford Diffraction presents latest X-ray diffraction technologies at 2019 BCA Spring Meeting

Rigaku Oxford Diffraction is also hosting a users’ meeting at the British Crystallographic Association Spring Meeting, presenting its latest X-ray diffraction innovations April 16, 2019 – Nottingham, UK. Rigaku Corporation is pleased to announce its attendance at the British Crystallographic Association Spring Meeting (BCA 2019), Monday, April 15 to Thursday, April 18, 2019 at the... Read more

PerkinElmer Joins Accenture’s Life Sciences Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research

Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier WALTHAM, Massachusetts – April 16, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has joined Accenture’s open partner ecosystem, designed... Read more

Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 03 April 2019 Roche and Spark Therapeutics, Inc. announce withdrawal and refiling of Premerger Notification and Report Form under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has withdrawn its Premerger... Read more

QIAGEN launches novel liquid biopsy solutions and NGS panels with seamlessly integrated bioinformatics to support advances in cancer research

Germantown, Maryland, and Hilden, Germany, March 28, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of new solutions designed to advance cancer research as part of its highlights at the American Association for Cancer Research (AACR) 2019 Annual Meeting from March 29 to April 3, 2019, in Atlanta, Georgia. More... Read more

New Center for Spectroscopic Excellence

By John Burchell / March 25, 2019 Home / News / New Center for Spectroscopic Excellence JASCO Corporation (Tokyo Japan) is proud to announce a joint collaboration with the Department of Chemistry at the prestigious University of Pennsylvania (Philadelphia). The New Center for Spectroscopic Excellence was inaugurated at the end of March 2019. We are pleased to be working with the researchers... Read more